Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.4K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of <sup><b>19</b></sup>F NMR Spectroscopy for Determining the Absolute Configuration of α-Chiral Amines and Secondary Alcohols Using Trifluoromethylbenzoimidazolylbenzoic Acid.

The Journal of organic chemistry·2025
Same author

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

Basic & clinical pharmacology & toxicology·2024
Same author

Correction to "Axially Chiral Trifluoromethylbenzimidazolylbenzoic Acid: A Chiral Derivatizing Agent for α-Chiral Primary Amines and Secondary Alcohols To Determine the Absolute Configuration".

The Journal of organic chemistry·2024
Same author

Direct Multi-Deuterium Labelling of Pirtobrutinib.

Journal of labelled compounds & radiopharmaceuticals·2024
Same author

Nucleoside Cation Radicals: Generation, Radical-Induced Hydrogen Atom Migrations, and Ribose Ring Cleavage in the Gas Phase.

Journal of the American Society for Mass Spectrometry·2024
Same author

Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand.

Journal of labelled compounds & radiopharmaceuticals·2024

Related Experiment Video

Updated: Sep 11, 2025

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

6.7K

Synthesis of [3H]muscimol.

Michal Kriegelstein1, Aleš Marek1

  • 1Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czechia.

Journal of Labelled Compounds & Radiopharmaceuticals
|August 12, 2025
PubMed
Summary

Researchers developed a new method to synthesize [3H]muscimol, a key compound for studying GABA A receptors. This novel approach provides a safer and more efficient way to produce this valuable radioligand for neurochemical research.

Keywords:
3H NMRB3H3GABA[3H]muscimoltritioboranetritium

More Related Videos

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
11:04

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine

Published on: June 13, 2022

3.1K
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

3.2K

Related Experiment Videos

Last Updated: Sep 11, 2025

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

6.7K
Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
11:04

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine

Published on: June 13, 2022

3.1K
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

3.2K

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Organic Synthesis

Background:

  • Muscimol is a crucial GABA A receptor agonist used in neurochemical research.
  • Existing methods for synthesizing high-specific-activity [3H]muscimol are limited and challenging.
  • Access to reliable radiolabeled muscimol is essential for GABA receptor studies.

Purpose of the Study:

  • To develop a novel and efficient synthetic route for preparing [3H]muscimol.
  • To overcome the limitations of conventional radiolabeling strategies for muscimol.
  • To provide a safe and reliable method for producing high-specific-activity [3H]muscimol.

Main Methods:

  • A four-step synthesis of a protected amide precursor from dimethyl acetylenedicarboxylate.
  • In situ generation of tritioborane (BT3·THF) for reductive labeling.
  • Electrophilic reduction of the precursor followed by deprotection.

Main Results:

  • The novel synthesis yielded [3H]benzyl-protected muscimol with a radiochemical yield of 44 mCi and molar activity of 48.3 Ci/mmol.
  • Final deprotection produced [3H]muscimol·HBr with >95% radiochemical purity.
  • The method successfully avoids the use of bulk tritiated water.

Conclusions:

  • A new, safe, and efficient method for synthesizing [3H]muscimol has been established.
  • This approach offers improved access to a valuable radioligand for GABA receptor research.
  • The developed protocol represents a significant advancement in radiochemical synthesis for neurochemical tools.